TIRZEPATIDE FOR WEIGHT LOSS

CHARLOTTE NC | MATTHEWS NC

(704) 243-7106

Faster Weight Loss Made Easier!

Tirzepatide for weight loss is a safe, powerful appetite suppressant that allows you to lose weight with less effort by reducing appetite and keeping you feeling full.

More About Tirzepatide for Weight Loss

Tirzepatide for Weight Loss is an approved non-stimulant (safe for patients with cardiovascular disease), non-addictive (not a controlled substance) weekly injection. It uses painless, weekly injection into belly fat with a tiny needle to reduces appetite and food cravings while increasing feeling of fullness. Tirzepatide has been shown to produce even greater reductions of blood sugar and weight as compared to Semaglutide for weight loss (and Semaglutide works very well).

FAQs about Tirzepatide for Weight Loss

Tirzepatide is very effective for weight loss. In clinical trials, people with obesity who took the medication for 72 weeks lost an average of 15-20% of their body weight. Majority of patients had at least 15% weight loss at the 5 MG dose! This is a significantly greater amount of weight loss than what is typically seen with other weight loss medications.

Tirzepatide works by acting on two different hormones in the body: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 and GIP are hormones that are released from the gut after eating. They work to lower blood sugar levels, slow stomach emptying and suppress appetite.

Tirzepatide mimics the effects of GLP-1 and GIP, which helps to promote weight loss. It also helps to reduce hunger and cravings, and it makes people feel full after eating.

Tirzepatide is a once-weekly injection, which can make it easier to take than other weight loss medications that need to be taken more often. It is also generally well-tolerated, with most side effects being mild and temporary.

It is important to combine Tirzepatide with a healthy diet and exercise routine to achieve and maintain long-term weight loss.

Tirzepatide for weight loss works by acting on 2 cellular receptors. It mimics 2 peptide hormones; glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) that targets areas of the brain that regulate appetite and food intake; it is a powerful appetite suppressant. Tirzepatide has even been shown to produce greater reductions of blood sugar and weight as compared to selective GLP-1 receptor agonists like Semaglutide.

Tirzepatide is a relatively new medication, but it has been studied extensively in clinical trials. Overall, it appears to be a safe and effective medication for the treatment of type 2 diabetes and obesity.

The most common side effects of Tirzepatide are gastrointestinal (GI) in nature, such as nausea, vomiting, diarrhea, and constipation. These side effects are typically mild to moderate and occur more often when starting treatment or increasing the dose. Most GI side effects resolve on their own within a few weeks or months.

Other potential side effects of Tirzepatide include:

  •  Low blood sugar (hypoglycemia)
  •  Allergic reactions
  •  Pancreatitis
  •  Gallbladder problems
  •  Increased thyroid hormone levels (hyperthyroidism)
  •  Depression

Tirzepatide is not recommended for people with a history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or pancreatitis. It is also not recommended for people who are pregnant or breastfeeding.

Overall, Tirzepatide is a safe and effective medication for the treatment of type 2 diabetes and obesity. However, it is important to be aware of the potential side effects and to talk to your medical provider about whether Tirzepatide is right for you.

You are NOT a good candidate for Tirzepatide if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, gall bladder disease, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2.

The most common side effects of Tirzepatide are gastrointestinal (GI) in nature, such as nausea, vomiting, diarrhea, and constipation. These side effects are typically mild to moderate and occur more often when starting treatment or increasing the dose. Most GI side effects resolve on their own within a few weeks or months.

Other potential side effects of Tirzepatide include:

  •  Low blood sugar (hypoglycemia)
  •  Allergic reactions
  •  Pancreatitis
  •  Gallbladder problems
  •  Increased thyroid hormone levels (hyperthyroidism)
  •  Depression
Medication Disclosures: These injectable medications are obtained from compounding pharmacies licensed by the State Board of Pharmacy. Compounding pharmacies are currently able to produce these medications due to supply shortages as listed on the FDA Drug Shortage website. Compounded products are not evaluated by the FDA nor do they receive separate FDA approval, even if the branded parent compound is FDA approved. Our programs are NOT affiliated with Novo Nordisk or Eli Lily and Company.